We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Receptor Blueprint Helps Design Osteoporosis Drugs

News   Nov 20, 2018 | Original story from University of Zurich

 
Receptor Blueprint Helps Design Osteoporosis Drugs

The receptor is the key regulatory switch controlling calcium release from bones, and thus a prime target for developing new drugs for the treatment of osteoporosis. The receptor consists of an extracellular part (purple) and a part that resides in the membrane (green). Parathyroid hormone (orange) activates the receptor. Credit: University of Zurich

 
 
 

RELATED ARTICLES

Liver Fibrosis “Off Switch” Could Help Fight Alcoholic Liver Disease

News

Understanding the process of liver fibrosis, could help researchers develop new ways to prevent or treat conditions such as alcoholic liver disease. A team has now demonstrated for the first time that liver fibrosis progression could potentially be targeted by manipulating a special population of liver cells.

READ MORE

Taking Aim at Gastric Cancer

News

A team has discovered that a novel drug, called “FerriIridium”, is capable of simultaneously diagnosing and treating gastric cancer.

READ MORE

Curvy Cancer-causing Bacterium "Keeps in Shape”

News

New insights into how the cancer-causing stomach bacterium keeps its shape could pave the way for the creation of more-specialized antibiotics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE